G.R. Galstyan
HYPOGLYCEMIC EFFECTS OF FLOZINES COMPARED TO SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
6-10 |
I.G. Rybkina, E.E. Petryaikina, I.E. Koltunov
10-YEAR ANNIVERSARY OF THE USE OF INSULIN PUMP THERAPY IN PEDIATRIC PRACTICE IN MOSCOW
|
11-14 |
E.A. Strebkova, L.I. Alekseeva
OSTEOARTHROSIS AND METABOLIC SYNDROME
|
15-19 |
A.A. Markovich (1), M.B. Antsiferov (2)
NEW APPROACHES TO DIAGNOSIS AND TREATMENT OF NEUROENDOCRINE TUMORS
|
20-27 |
A. V. Starodubova, O. A. Kislyak
OBESITY AS A RISK FACTOR FOR CARDIOVASCULAR DISEASES. LITERATURE REVIEW
|
28-34 |
A.F. Verbovoy, L.A. Sharonova, O. V. Kosareva, Yu.A. Dolgikh, N. I. Verbovaya
HYPOTHYROIDISM AND CARDIOVASCULAR DISEASES
|
36-41 |
M.B. Antsiferov (1), T.P. Nikitina (2), A.Yu. Rodionova (3), K.A. Kurbatova (2), T.I. Ionova (2)
HYPOGLYCEMIA AND QUALITY OF LIFE OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
42-49 |
A.F. Verbovoy, I.A. Tsanava, N.I. Verdovaya
ADIPOKINES AND HORMONAL AND METABOLIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND GOUT
|
50-54 |
N.A. Demidov (1), S.K. Zakharova (2), A.N. Zavyalov (3)
THE RESULTS OF MONITORING OF THE EFFECTIVENESS AND SAFETY OF RECOMBINANT HUMAN INSULIN PREPARATIONS BIOSULIN R AND BIOSULIN N IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CLINICAL PRACTICE
|
55-59 |
A.F. Verbovoy (1), O.N. Reshetova (2), I.A. Fomina, I.A. Tsanava (1)
GHRELIN AND LEPTIN IN YOUNG MEN WITH PUBERTY-ONSET OBESITY AFTER THE ORAL GLUCOSE TOLERANCE TEST
|
60-63 |
L.A. Ruyatkina (1), M.Yu. Sorokin (2)
POTENTIALS FOR THE APPLICATION OF INSULIN DETEMIR IN THE TREATMENT OF DIABETES MELLITUS IN PREGNANCY: PROVEN ADVANTAGES AND PROSPECTS FOR THE USE
|
64-71 |